Sanyo Trading Co.,Ltd. FY2026 Q3 Earnings Report

Quick View

Executive Summary

This quarterly financial performance reflects double-digit profit growth, driven by higher revenue and profit in the core businesses, as well as non-recurring factors such as foreign exchange gains and gains on the sale of investment securities. Revenue was ¥1,075.3B (+8.8% YoY), Operating Income was ¥65.6B (+18.5%), Ordinary Income was ¥67.1B (+11.2%), and Net Income was ¥54.1B (+18.4%), with all figures exceeding the previous year. The primary drivers of profit growth were earnings growth in the Fine Chemicals and Industrial Products segments, supplemented by a ¥4.0B foreign exchange gain and a ¥12.7B gain on the sale of investment securities.

Factors Affecting Financial Performance

【Revenue】Revenue was ¥1,075.3B, an increase of +8.8% YoY. By segment, Fine Chemicals generated ¥391.2B (36.4% of total, +8.5%), Industrial Products generated ¥310.4B (28.9%, +7.0%), Life Science generated ¥334.4B (31.1%, +4.9%), and Sustainability generated ¥97.1B (9.0%, +10.7%), with all four major segments reporting higher revenue.

【Profit and Loss】Operating Income was ¥65.6B (+18.5%), representing profit growth that outpaced revenue growth and indicating operating leverage. The gross profit margin was 17.7% and the operating margin was 6.1%, both improving from the previous year. By segment, Industrial Products (profit of ¥27.8B, +21.5%) and Fine Chemicals (¥25.4B, +28.8%) led profit growth, while Sustainability reported lower profit of ¥9.5B (-27.3%) despite higher revenue, indicating a change in the business mix. Ordinary Income was ¥67.1B, boosted by a ¥4.0B foreign exchange gain. Net Income was ¥54.1B, with extraordinary income of ¥14.9B, including a ¥12.7B gain on the sale of investment securities and a ¥1.5B gain on the recognition of negative goodwill, providing a boost to Profit Before Tax. Overall, the results represent higher revenue and profit, with contributions from both improved profitability in the core businesses and non-recurring factors.

Segment Analysis

Industrial Products is the largest pillar in terms of both its contribution and profitability, with Operating Income of ¥27.8B (9.0% margin). Fine Chemicals generated profit of ¥25.4B (6.5% margin), showing the highest profit growth rate at +28.8%. Life Science generated profit of ¥16.3B (4.9% margin), with a relatively low margin. Sustainability reported lower profit of ¥9.5B (-27.3%) despite a +10.7% increase in revenue; its profit margin declined from 9.8%, making it the only segment in the portfolio to report lower profit. Other segments recorded an operating loss of ¥3.7B (-48.8%) and served as an adjustment factor for the company as a whole.

Key Financial Indicators

【Profitability】The operating margin was 6.1% (5.6% in the previous year), while the net profit margin was 5.0% (4.6% in the previous year); both improved, primarily because growth in gross profit exceeded growth in SG&A expenses. 【Cash Quality】Asset balances increased, with inventory at ¥278.5B and notes and accounts receivable at ¥244.1B, indicating a buildup in working capital. 【Capital Efficiency】ROE was 9.7%, with the improvement in the net profit margin serving as the primary driver. 【Financial Soundness】The Equity Ratio remained high at 63.9% (62.9% in the previous year). Short-term borrowings were reduced from ¥12.6B to a level of ¥12.6B, while long-term borrowings were ¥1.0B, indicating a small amount of interest-bearing debt. Cash and deposits were ¥119.8B, reflecting a conservative financial structure.

Cash Flow Analysis

As detailed disclosure of the statement of cash flows is not available, funding trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥119.8B, remaining almost flat from ¥119.0B in the previous year. Meanwhile, inventories increased to ¥278.5B (¥259.9B in the previous year), and notes and accounts receivable increased to ¥244.1B (¥236.8B in the previous year), with the accumulation of working capital serving as a factor behind the retention of funds. Accounts payable and notes payable increased to ¥154.5B (¥125.4B in the previous year), partially offsetting this effect. Contract liabilities increased to ¥90.7B (¥81.2B in the previous year), with advance receipts supporting liquidity. Short-term borrowings were on a downward trend, suggesting that repayments using internally generated funds are progressing. Overall, funds generated from operating activities are prone to being absorbed by increases in inventories and receivables, and attention should be paid to the timing of cash generation.

Earnings Quality

Of the ¥7.0B in non-operating income recorded during the current period, foreign exchange gains accounted for ¥4.0B and were the primary factor driving Ordinary Income higher. In addition, extraordinary income of ¥14.9B was recorded, including a ¥12.7B gain on the sale of investment securities, a ¥1.5B gain on the recognition of negative goodwill, and a ¥0.7B gain on the sale of fixed assets. Accordingly, a certain portion of Profit Before Tax of ¥82.1B was attributable to non-recurring factors. The gap between Ordinary Income of ¥67.1B and Net Income of ¥54.1B, through Profit Before Tax of ¥82.1B, is primarily attributable to extraordinary income; therefore, its repeatability in subsequent periods is considered low. From an accrual perspective, increases in inventories and receivables have outpaced profit growth, and the increase in Operating Income may not have translated directly into an improvement in Operating Cash Flow. Accordingly, when assessing earnings quality, emphasis should be placed on the sustainability of core Operating Income.

Earnings Forecast and Guidance

Progress toward the full-year forecast was 77.9% for Revenue (¥1,075.3B/¥1,380.0B), 87.4% for Operating Income (¥65.6B/¥75.0B), and 87.8% for Ordinary Income (¥67.1B/¥76.5B), all exceeding the simple time-based progress benchmark of approximately 75% for cumulative Q3 results. The fact that progress in profit-related indicators exceeded progress in Revenue reflects not only contributions from non-recurring factors such as extraordinary income and foreign exchange gains, but also margin improvement in the core businesses. The earnings forecast was revised during the current quarter, suggesting that management also recognizes the full-year trend of higher revenue and profit.

Shareholder Returns

An interim dividend of ¥30 per share was paid. The planned year-end dividend consists of an ordinary dividend of ¥15 plus a commemorative dividend of ¥10. Although a simple aggregation of the annual dividend total has not been made due to the impact of the share split (effective July 1, 2026, with 1 share split into 2 shares), on a pre-split basis, the year-end dividend is expected to be ¥30 (including a commemorative dividend of ¥20), resulting in an annual dividend equivalent of ¥80. Against the full-year Net Income forecast of ¥6.0B, the Payout Ratio calculated based on the annual dividend total on a pre-split basis (¥80 × the number of shares outstanding) is approximately in the 70% range, a relatively high level compared with historical dividend levels. There has been no disclosure regarding share repurchases, and the evaluation is based on the Payout Ratio from dividends alone.

Risk Factors

1. Working Capital Retention Risk: Inventory of ¥278.5B and notes and accounts receivable of ¥244.1B have increased in scale, potentially affecting the timing of Operating Cash Flow generation through longer DSO and DIO.

2. Segment Profitability Concentration Risk: The Sustainability Business reported higher revenue of +10.7% but lower Operating Income of ¥9.5B (-27.3%). The impact of changes in the portfolio mix on the overall profit margin needs to be monitored.

3. Dependence on Non-Recurring Factors: Of Net Income of ¥54.1B, extraordinary income of ¥14.9B, including a ¥12.7B gain on the sale of investment securities and a ¥1.5B gain on the recognition of negative goodwill, made a contribution. These are non-recurring factors with low repeatability in subsequent periods.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (trading)

Profitability and Returns

The company’s Operating Margin and Net Profit Margin both exceed the industry median, indicating that profitability is relatively high within the industry.

Growth and Capital Efficiency

The Revenue growth rate also exceeds the industry median, placing the company’s revenue growth among the higher levels within the industry.

※Source: Compiled by the Company

Key Takeaways from the Financial Results

1. The two core segments, Industrial Products and Fine Chemicals, led profit growth, improving the operating margin to 6.1%. Meanwhile, the Sustainability Business reported higher revenue but lower profit, and the widening profitability gap between segments is a key structural characteristic of the results.

2. Net Income of ¥54.1B includes extraordinary income such as gains on the sale of investment securities and the recognition of negative goodwill. Part of the gap with Ordinary Income of ¥67.1B is attributable to non-recurring factors. These factors must be distinguished when assessing full-year earnings capacity.

3. Progress toward the full-year forecast was high, at 87.4% for Operating Income and 87.8% for Ordinary Income, and the earnings forecast was revised during the period. While the financial foundation remains conservative, as indicated by an Equity Ratio of 63.9% and a trend toward lower interest-bearing debt, the accumulation of working capital from increases in inventories and receivables is a key point to monitor when assessing future cash flow trends.

Theoretical Stock Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson type with an explicit 5-year fade). It is not a forecast of the market price or a recommendation to take any specific investment action.

Sensitivity: ¥997–¥1,056 at Cost of Equity ±1%, and ¥1,024–¥1,028 at ω±0.1.

Notes:

• As progress toward the full-year forecast for Net Income (90%) exceeds the standard benchmark (75%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies with progress ahead of schedule tend to exceed their forecasts; the adjustment may be excessive for businesses with strong seasonality).
• Net assets at the end of the quarter are used (there is a timing difference from the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model / Interest Rate Reference Month: 2026-07 / This value does not predict or guarantee the future stock price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional advisor as necessary.

---End of Report---